Swiss National Bank Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Swiss National Bank increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the third quarter, Holdings Channel.com reports. The fund owned 1,052,800 shares of the medical equipment provider’s stock after purchasing an additional 3,400 shares during the period. Swiss National Bank’s holdings in Intuitive Surgical were worth $517,209,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC raised its stake in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at $26,000. Godsey & Gibb Inc. raised its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. LRI Investments LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at $30,000. Finally, LGT Financial Advisors LLC raised its stake in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $527.61 on Friday. The company has a fifty day moving average of $499.29 and a 200 day moving average of $457.89. Intuitive Surgical, Inc. has a fifty-two week low of $295.02 and a fifty-two week high of $544.38. The company has a market capitalization of $187.92 billion, a P/E ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. This represents a 93.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 396 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $486.88, for a total transaction of $192,804.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,680,761.28. The trade was a 6.71 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 91,178 shares of company stock valued at $45,897,071 in the last 90 days. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Piper Sandler reiterated an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial upped their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Mizuho upped their price objective on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Royal Bank of Canada upped their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Finally, BTIG Research set a $535.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.